Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS England

This public procurement record has 1 release in its history.

Award

22 Apr 2025 at 17:48

Award Notice
Summary of the contracting process

The NHS England has concluded the procurement process for the "NHS Framework Agreement for Branded Medicines - Proprietary Category Tender". This open procedure aims to secure pharmaceutical products and is classified under industry category code 33600000. The contract, valued at approximately £1.24 billion, covers various regions throughout the UK, including the East Midlands, London, and Yorkshire amongst others, as well as Guernsey and Jersey. The procurement process is currently at the award stage, having been completed on 24th March 2025, with the contract period running from 1st May 2025 to 30th April 2029.

This tender presents extensive opportunities for business growth, particularly for firms involved in the pharmaceutical industry supplying branded medicines. Small and medium-sized enterprises (SMEs) are particularly encouraged to participate, given the framework's suitability considerations. Companies with the capability to deliver high-quality pharmaceutical products across multiple regions in the UK and the Channel Islands will find this tender particularly advantageous, as it provides a substantial and sustained business opportunity over four years.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Notice Description

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/4a5ea1b7-0f6a-4932-8bab-c6b56466516d
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,241,520,444 £1B-£10B
Lots Value
Not specified
Awards Value
£1,241,520,444 £1B-£10B
Contracts Value
Not specified

Notice Dates

Publication Date
22 Apr 20251 years ago
Submission Deadline
9 Dec 2024Expired
Future Notice Date
Not specified
Award Date
24 Mar 20251 years ago
Contract Period
1 May 2025 - 30 Apr 2029 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
72
Supplier Names

CSL Behring UK Ltd

Mylan

Abbvie Ltd

Lupin Healthcare UK Ltd

Celix Pharma Ltd.

Morningside Pharmaeuticals

Day Lewis Medical Ltd

Zentiva Pharma UK Ltd

Aspire Pharma Ltd

Takeda UK Limited

Pfizer Ltd

Merz

Mercury Pharmaceuticals Ltd

Infectopharm Ltd

Synchrony

medac Pharma LLP

Recordati Rare Diseases UK Ltd

Teva UK Limited

Sandoz Ltd

Ranbaxy (UK) Ltd

Neon Healthcare Ltd

Accord-UK Ltd

Colonis Pharma Ltd

Provepharm UK Ltd

Organon Pharmaceuticals UK Ltd

Neuraxpharm UK Ltd

Kyowa Kirin International UK New Co Ltd

BioCryst Ireland Limited

Bayer Plc

Essential Pharma

ROVI Biotech Ltd

Wockhardt UK Limited

Glenmark Pharmaceuticals Europe Ltd

Selective Supplies Ltd

CST Pharma Limited

Otsuka Pharmaceuticals UK Limited

Chiesi Limited

Baxter Healthcare Ltd

Pharming Group

Janssen-Cilag Ltd

Ipsen

Pharmasure Ltd

Dexcel Pharma Ltd

Besins Healthcare UK LTD

Astellas Pharma Ltd

Merck Serono Limited

Orifarm UK Ltd

SERB SA

Drugsrus Ltd

Grunenthal

Galen Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

Intrapharm Laboratories Ltd

Novo Nordisk

Xiromed

Strandhaven Ltd t/a Somex Pharma

Nordic Pharma Ltd

Ridge Pharma

Gerot Lannach UK Ltd

Theramex HQ UK

Ferring Pharmaceuticals Ltd

Aspen Pharmacare UK Limited

Eisai Ltd

Novartis Pharmaceuticals UK Limited

Alissa Healthcare Research Limited

Tillomed Laboratories ltd

Gedeon Richter UK Ltd

Napp Pharmaceuticals Ltd

Rayner Pharmaceuticals Ltd

Norgine Pharmaceuticals Limited

THORNTON & ROSS LIMITED

Flynn Pharma Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...